The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.
about
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseasesEfficacy and safety of sirolimus in lymphangioleiomyomatosis.The tuberous sclerosis complexOptimizing treatments for lymphangioleiomyomatosisLymphangioleiomyomatosis: differential diagnosis and optimal managementSex-specific lung diseases: effect of oestrogen on cultured cells and in animal modelsManagement of lymphangioleiomyomatosisClinical features, epidemiology, and therapy of lymphangioleiomyomatosisLung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM RegistryPulmonary artery pressure in lymphangioleiomyomatosis: an echocardiographic study.Risk of spontaneous pneumothorax due to air travel and diving in patients with Birt-Hogg-Dubé syndrome.Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening methodSerum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.Reversible airflow obstruction in lymphangioleiomyomatosis."Getting stuck with LAM": patients perspectives on living with lymphangioleiomyomatosis.Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response.The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.Involvement of lymphatics in lymphangioleiomyomatosisClinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosisA nationwide survey of lymphangioleiomyomatosis in Korea: recent increase in newly diagnosed patients.A National Heart, Lung, and Blood Institute history and perspective on lymphangioleiomyomatosis.Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis.Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are goingChanges in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.Unusual causes of pneumothoraxSerum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trialThe role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosisRetrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosisSustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules.Pulmonary arterial involvement leading to alveolar hemorrhage in lymphangioleiomyomatosis.Prevalence of uterine leiomyomas in lymphangioleiomyomatosisPredictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis.Age and Sex of Mice Markedly Affect Survival Times Associated with Hyperoxic Acute Lung InjuryA 48-year-old woman with lymphangioleiomyomatosis.
P2860
Q24608283-7343AA74-B5A6-4AE6-A27D-A558352851BCQ24610039-27ED95ED-97B2-4563-BCA0-CF425D64C36BQ24628011-5D041622-13E4-4BC8-9EF3-B4DD010088ADQ26865250-ED24B4F6-208B-4835-81E4-94373ADEF558Q27022412-91B93CF3-D42C-42EC-8291-0B1BD4847F63Q27687650-24985893-FE6D-43A0-B3E8-284539F4132BQ28084725-A74917F9-22E4-439F-AAFE-DFABC48AE1CFQ28084975-639899D2-628D-4304-A2DE-85F4C4B1C6D6Q28755243-4075B376-253A-442E-83C2-0E4EFCCEF7B7Q30479456-CDE48C49-F35F-4B42-98E2-E92DFF014DD4Q33468846-F145D4DD-83B3-4C4E-B1E4-89DF7BDCA077Q33587163-06CB8273-9D75-490A-B2A5-79D367A1E281Q33637626-93E1346D-2CA0-4C91-8AD1-4F12DA9F94BBQ33639768-678BE3CF-A77B-488B-A49E-6A92E6B65D53Q33685049-5B9E98BA-5585-4824-8FA0-3F7E80424184Q33823877-C6D6314B-AFFC-43E4-BF9E-E5DB1DDF5700Q33905090-37D44D16-EAF4-4E0E-B491-35F6D86E53D8Q33905141-2882F27D-1EAF-4B52-91B3-C303836B9582Q33905175-09491CE9-70E4-47B8-82A1-9979E9D803DFQ33963293-6EE5A01F-2988-4632-9485-B93C3399343CQ34009330-07E08CE8-1CF7-4A5D-88A4-B1A564213ED7Q34014774-55529D06-4CA7-4200-9D2B-532F010DCBB2Q34129641-67A32273-6CEF-454B-8CEB-A93BEFB2B5C1Q34160683-EA2223D3-65D8-4FDF-BEBE-96AAAEDABE54Q34167429-7E4F84B7-BC33-4A89-8975-CDDCA5D100E2Q34194187-F4519F5D-EAAD-4233-884F-A7D429D3DB71Q34375358-588FE9B9-8C39-4088-8F52-46339542688BQ34380247-EE459482-0ABC-45AC-BB84-DBBD4A9FBA06Q34496096-53AC9D34-1309-4DFB-87FD-181C51A184F9Q34536450-446DC9F2-FADC-4317-80F3-14605928B5A0Q34560457-190DCB9F-F8AE-4EB5-98D7-E7CC69E2487CQ34840298-DF9238D8-8C70-4AD6-8329-F0AB5D9F88A0Q35044713-87F76C7C-DA68-41FB-8998-BF85E473C757Q35049412-129A52BA-FD69-46C2-802F-564C3BA9CAF6Q35140982-3B9737D6-7B2D-4384-940E-99D3B6625BCCQ35142017-CD51CA40-9E68-487D-9055-06A39B569D58Q35190953-1DB91F7D-ACED-4DF0-A6BE-B8E8AD5EB80CQ35531599-FDB6FA67-632E-4214-8BA4-95B3BFDE68DBQ35672033-71F8E455-F87D-4203-B955-30C5DBF6509EQ35752955-C98C0192-9226-46A3-B8AD-58C763CDA7CF
P2860
The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 October 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The NHLBI lymphangioleiomyomat ...... of 230 patients at enrollment.
@en
The NHLBI lymphangioleiomyomat ...... of 230 patients at enrollment.
@nl
type
label
The NHLBI lymphangioleiomyomat ...... of 230 patients at enrollment.
@en
The NHLBI lymphangioleiomyomat ...... of 230 patients at enrollment.
@nl
prefLabel
The NHLBI lymphangioleiomyomat ...... of 230 patients at enrollment.
@en
The NHLBI lymphangioleiomyomat ...... of 230 patients at enrollment.
@nl
P2093
P2860
P1476
The NHLBI lymphangioleiomyomat ...... of 230 patients at enrollment
@en
P2093
Angelo Taveira-Dasilva
Barry L Fanburg
Eric J Olson
Gerald J Beck
Geraldine A Finlay
Hannah H Peavy
Janet R Maurer
Jar-Chi Lee
Jeffrey T Chapman
P2860
P304
P356
10.1164/RCCM.200409-1298OC
P407
P577
2005-10-06T00:00:00Z